Aquilo Capital Management, LLC Immatics N.V. Transaction History
Aquilo Capital Management, LLC
- $64.3 Million
- Q4 2024
A detailed history of Aquilo Capital Management, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 373,902 shares of IMTX stock, worth $1.81 Million. This represents 4.14% of its overall portfolio holdings.
Number of Shares
373,902
Previous 333,502
12.11%
Holding current value
$1.81 Million
Previous $3.81 Million
30.14%
% of portfolio
4.14%
Previous 2.96%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
92.5MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$51.3 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA10.4MShares$50.4 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$45.4 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$35.2 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$31.7 Million0.76% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $369M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...